From March 10, 2022 to June 30, 2022, the company has repurchased 3,620,000 shares, representing 0.5% for CNY 27.3 million. With this, the company has completed the repurchase of 3,620,000 shares, representing 0.5% for CNY 27.3 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.73 CNY | +0.21% | +1.94% | -14.47% |
1st Jan change | Capi. | |
---|---|---|
-14.47% | 458M | |
+21.08% | 43.7B | |
+29.65% | 23.11B | |
+19.16% | 14.31B | |
+54.66% | 12.87B | |
-0.05% | 6.79B | |
-11.27% | 6.45B | |
-8.87% | 5.73B | |
+12.21% | 5.55B | |
+9.49% | 4.81B |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on March 10, 2022.